1.45 USD
↗ 0.11 (8.21%)AT CLOSE (11:59 AM EDT)
Alzamend Neuro, Inc. Common Stock
ALZNNASDAQ • USD
1.44
↘ 0.01 (0.69%)
POST MARKET (AS OF 07:34 PM EDT)
Post Market
AS OF 07:34 PM EDT
1.44
↘ 0.01 (0.69%)
Market: CLOSED
ALZN is currently priced at $1.43. There is a divergence between signals — technical indicators rate "Strong Buy" but underlying fundamentals lean "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Furthermore, ALZN is currently richly valued, trading at a premium to sector peers across key valuation metrics.
Technical & fundamental data as of Aug 4, 2026.
Open?$1.38
High?$1.45
Low?$1.34
Prev. Close?$1.34
Volume?149.6K
Avg. Volume?236.3K
VWAP?$1.39
Rel. Volume?0.63x
Bid / Ask
Bid?$1.43 × 600
Ask?$1.45 × 202.3K
Spread?$0.02
Midpoint?$1.44
Valuation & Ratios
Market Cap?6.9M
Shares Out?4.8M
Float?3.8M
Float %?98.6%
P/E Ratio?N/A
P/B Ratio?9.48
EPS?-$1.83
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's disease. The Company has two therapeutic drug candidates, AL001 and ALZN002. Its pipeline consists of AL001, a patented ionic cocrystal technology delivering lithium through a therapeutic combination of lithium, proline and salicylate; and ALZN002, a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's disease.
Address
480 PEACHTREE ROAD NE, SECOND FLOOR
ATLANTA, GA 30326
Phone: 844-722-6333
ATLANTA, GA 30326
Phone: 844-722-6333
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+2/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?50
Short Sent.?43
Piotroski F-Score?0/9Weak
Altman Z-Score?-55.89Distress
Confidence?51%Low
Short InterestElevated
Short % of Float?8.75%Elevated
Short Interest?328.3K
Days to Cover?1.1
Free Float3.8M
Avg Daily Volume314.1K
Settlement Date2026-07-15
Financial Health
Current Ratio?1.31Adequate
Quick Ratio?1.31Adequate
Cash Ratio?0.53Adequate
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score67/100
P/E?N/A▾
P/B?9.48HIGH▾
Peers100
S&P20
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-0.7CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-1,196.4%WEAK▾
S&P3
ROA?-421.9%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$6.2M
Fundamentals ratios updated end of day